VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LFST
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LFSTLifeStance Health Group, Inc.
$14.17$5.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
LFST logo

LifeStance Health Group, Inc.

LFST
NASDAQ · Healthcare Providers
$14.17
At close - Nov 17, 4:00 PM EST - USD
Market Cap$5.5B
P/E77.1x
52W High$15.66
Volume6.32M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Reaccelerating Growth Meets Thin Margins and Stock Comp Dependence

LifeStance's revenue growth has reaccelerated to 26.1% year over year in Q2 2026, and operating margin has swung from -0.9% to 7.0% over the same period, suggesting emerging operating leverage.

GrowthAccelerating
ProfitabilityModerate
ValuationExpensive
TechnicalsStrong
Explore valuation models
MARKET ACTION

LFST price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

11/12 Beats

EPS beat 11 of last 12 quarters

02

Valuation risk

+248% Peers

P/E is 248% above peer median

03

Market leadership

RS 96 · Leader

High momentum (Outperforming 96% of market)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystEstimated earnings · Feb 5

Market performance

Price History →

Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
LFST+103.59%
S&P 500 (^GSPC)+7.21%
1-Year Return
LFST+126.72%
S&P 500 (^GSPC)+10.03%
3-Year Return
LFST+129.66%
S&P 500 (^GSPC)+57.08%
5-Year Return
LFST+51.23%
S&P 500 (^GSPC)+65.84%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
74.9x
Forward P/E
84.9x
EV/EBITDA0th %ile
33.0x
FCF YieldCash Flow
4.0%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
74.9x
352.0x
0th· Low
EV/EBITDA
33.0x
79.4x
0th· Low
Price/FCF
24.8x
32.6x
0th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$4.22-70.2%
Base (Fair)$7.80-44.6%
Bull$9.18-35.2%
$4.22 Bear$7.80 Base$9.18 Bull
Current Market Price: $14.17
Trades at a 81.7% premium to Base DCF ($7.80)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$1.42B+13.9% YoY
Net income FY25
$10M+116.8% YoY
Free cash flow FY25
$110M+28.4% YoY
Operating margin FY25
1.7%+4.2 pts YoY
ROIC (FY25)1.1%
Avg ROIC 5Y-6.3%
ROE (TTM)4.8%
Piotroski Score8 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate11/12 (92%)
Revenue Beat Rate8/12 (67%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 5, 2026
$0.06+62.7%
vs $0.04
$456M+5.6%
vs $432M
Q3 2026
Aug 6, 2026
$0.06+83.2%
vs $0.03
$435M+5.0%
vs $415M
Q2 2026
May 7, 2026
$0.04+300.0%
vs $0.01
$404M+4.1%
vs $387M
Q1 2026
Feb 25, 2026
$0.03
vs -$0.00
$382M+1.0%
vs $378M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Seeking Alpha·1d ago
Healthcare Stocks Overtake Tech: 5 Strong Buys Combining Growth And Value

Healthcare's emerging leadership combines defensive demand with long-term growth; the sector has gained over 22% year-to-date and more than 11% over one month. Five Quant Strong Buy stocks in the sector offer compelling growth opportunities, supported by strong earnings momentum, improving profitability, and positive analyst revisions. Healthcare services benefit from aging demographics, expanding patient demand, technological innovation, and operating efficiencies that support revenue growth and margin expansion.

Zacks Investment Research·Nov 9, 2026
Surging Earnings Estimates Signal Upside for LifeStance Health (LFST) Stock

LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

GlobeNewsWire·Nov 9, 2026
LifeStance Health Group Announces Pricing of Secondary Public Offering

SCOTTSDALE, Ariz., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 45,000,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”), at a public offering price of $13.12 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) from certain stockholders of the Company (the “Selling Stockholders”).

GlobeNewsWire·Nov 9, 2026
LifeStance Health Group Announces Launch of Secondary Public Offering

SCOTTSDALE, Ariz., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 45,000,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

Filtered for LifeStance Health Group, Inc.More Headlines
04

Compare before deciding

Benchmark LFST against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for LifeStance Health Group, Inc. (LFST)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
LFST logoLFSTLifeStance Health Group, Inc.Current
$14.17$5.5B77.0913.85%4.29%4.82%—
ACHC logoACHCAcadia Healthcare Company, Inc.
$37.94$3.53B-3.095.04%-33.07%-51.55%—
UHS logoUHSUniversal Health Services, Inc.
$191.98$11.62B7.779.71%7.96%19.27%0.41%
SGRY logoSGRYSurgery Partners, Inc.
$26.85$3.51B-39.776.24%-2.59%-2.67%—
OPCH logoOPCHOption Care Health, Inc.
$31.63$4.97B22.1213.03%3.74%16.36%—
ENSG logoENSGThe Ensign Group, Inc.
$186.02$10.84B27.6418.72%7.03%16.61%0.13%

Compare LFST vs Peers

LifeStance Health Group, Inc. (LFST) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ACHC

Most directly comparable listed peer for LFST.

Scale Benchmark

vs UNH

Larger-name benchmark to compare LFST against a more recognizable public peer.

Peer Set

Compare Top 5

vs ACHC, UHS, SGRY, OPCH

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

LFST SEC Filings & Documents

LifeStance Health Group, Inc. (LFST) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 6, 2026·SEC

Material company update

Jul 7, 2026·SEC

Material company update

Jun 4, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 25, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 28, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 6, 2026·SEC

FY 2026

May 7, 2026·SEC

FY 2025

Nov 6, 2025·SEC

Get notified when LFST posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

LFST Frequently Asked Questions

LifeStance Health Group, Inc. (LFST) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is LifeStance Health Group, Inc.'s revenue?

LifeStance Health Group, Inc. (LFST) reported $1.68B in revenue over the trailing twelve months. Revenue was $1.42B in fiscal year 2025. That is 570% more than the $212.5M of fiscal year 2019.

How fast is LifeStance Health Group, Inc. growing?

LifeStance Health Group, Inc. (LFST) grew revenue by 22.6% over the trailing twelve months, compared with the twelve months before.

Is LFST profitable?

Yes. LifeStance Health Group, Inc. (LFST) earned $71.9M in net income over the trailing twelve months (a 4.3% net margin).

Dividend & Returns
What is LFST's return on equity?

LifeStance Health Group, Inc. (LFST) had a return on equity (ROE) of 4.8% over the trailing twelve months. That is below the market's typical 10-15%.

What is LifeStance Health Group, Inc.'s free cash flow?

LifeStance Health Group, Inc. (LFST) generated $215.4M in free cash flow over the trailing twelve months.

What if you invested $1,000 in LFST back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →